Serial Measurements of Splanchnic Vein Diameters in Rats Using High-Frequency Ultrasound by Bridget M. Seitz et al.
fphar-07-00116 April 29, 2016 Time: 12:49 # 1
ORIGINAL RESEARCH
published: 03 May 2016
doi: 10.3389/fphar.2016.00116
Edited by:
Nicolau Beckmann,
Novartis Institutes for BioMedical
Research, Switzerland
Reviewed by:
Nadezhda A. German,
Texas Tech University Health
Sciences Center, USA
Craig J. Goergen,
Purdue University, USA
*Correspondence:
Stephanie W. Watts
wattss@msu.edu
Specialty section:
This article was submitted to
Experimental Pharmacology and Drug
Discovery,
a section of the journal
Frontiers in Pharmacology
Received: 20 January 2016
Accepted: 18 April 2016
Published: 03 May 2016
Citation:
Seitz BM, Krieger -Burke T, FinkGD
and Watts SW (2016) Serial
Measurements of Splanchnic Vein
Diameters in Rats Using
High-Frequency Ultrasound.
Front. Pharmacol. 7:116.
doi: 10.3389/fphar.2016.00116
Serial Measurements of Splanchnic
Vein Diameters in Rats Using
High-Frequency Ultrasound
Bridget M. Seitz1, Teresa Krieger-Burke2, Gregory D. Fink1 and Stephanie W. Watts1*
1 Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, USA, 2 In Vivo Facility, Michigan
State University, East Lansing, MI, USA
The purpose of this study was to investigate serial ultrasound imaging in rats as a
fully non-invasive method to (1) quantify the diameters of splanchnic veins in real
time as an indirect surrogate for the capacitance function of those veins, and (2)
assess the effects of drugs on venous dimensions. A 21 MHz probe was used on
anesthetized male Sprague–Dawley rats to collect images containing the portal vein
(PV), superior mesenteric vein (SMV), abdominal inferior vena cava (IVC), and splenic
vein (SpV; used as a landmark in timed studies) and the abdominal aorta (AA). Stable
landmarks were established that allowed reproducible quantification of cross-sectional
diameters within an animal. The average diameters of vessels measured every 5 min
over 45 min remained within 0.75 ± 0.15% (PV), 0.2 ± 0.09% (SMV), 0.5 ± 0.12%
(IVC), and 0.38 ± 0.06% (AA) of baseline (PV: 2.0 ± 0.12 mm; SMV: 1.7 ± 0.04 mm;
IVC: 3.2 ± 0.1 mm; AA: 2.3 ± 0.14 mm). The maximal effects of the vasodilator
sodium nitroprusside (SNP; 2 mg/kg, i.v. bolus) on venous diameters were determined
5 min post SNP bolus; the diameters of all noted veins were significantly increased
by SNP, while mean arterial pressure (MAP) decreased 29 ± 4 mmHg. By contrast,
administration of the venoconstrictor sarafotoxin (S6c; 5 ng/kg, i.v. bolus) significantly
decreased PV and SpV, but not IVC, SMV, or AA, diameters 5 min post S6c bolus; MAP
increased by 6 ± 2 mmHg. In order to determine if resting splanchnic vein diameters
were stable over much longer periods of time, vessel diameters were measured every
2 weeks for 8 weeks. Measurements were found to be highly reproducible within
animals over this time period. Finally, to evaluate the utility of vein imaging in a chronic
condition, images were acquired from 4-week deoxycorticosterone acetate salt (DOCA-
salt) hypertensive and normotensive (SHAM) control rats. All vessel diameters increased
from baseline while MAP increased (67 ± 4 mmHg) in DOCA-salt rats compared to
SHAM at 4 weeks after pellet implantation. Vessel diameters remained unchanged in
SHAM animals. Together, these results support serial ultrasound imaging as a non-
invasive, reliable technique able to measure acute and chronic changes in the diameter
of splanchnic veins in intact rats.
Keywords: ultrasound, serial imaging, splanchnic veins, venous capacitance, venous diameter5, cardiovascular
diseases
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INTRODUCTION
Dysregulation of venous capacitance (venous volume at a given
transmural pressure) is proposed to contribute to the etiology
of heart failure, arterial hypertension, hepatic cirrhosis, pre-
eclampsia, postural hypotension and shock (Safar and London,
1987; Reilly et al., 2001; Stewart et al., 2004; Aardenburg et al.,
2005; Li et al., 2008; Burchell et al., 2013). Splanchnic veins,
located within the abdominal region, represent the largest blood
volume reservoir within the human body (Gelman, 2009), and
also exhibit the largest degree of active capacitance response
of all venous beds in the body (Tyberg, 2002). Therefore, they
play an important role in the regulation of the circulation
by affecting cardiac preload, and thus, cardiac output and
blood pressure. Early methods to study splanchnic venous
capacitance and its regulation were highly invasive and could
only be readily applied in experimental animals (Brooksby
and Donald, 1971). Later approaches that were applicable
to humans included examining the distribution of blood-
sequestered radionuclides (Schmitt et al., 2002), impedance
plethysmography (Leunissen et al., 1993), and direct imaging
of the large veins (Stewart and Montgomery, 2004). For
example, ultrasonographic assessment of the dimensions of
large veins [particularly the inferior vena cava (IVC)] has
been used to estimate venous capacitance as a measure of
intravascular volume status in patients with septic shock
(Schefold et al., 2010) and in patients on hemodialysis (Brennan
et al., 2006).
Recent advancements in ultrasound technology include the
development of high-frequency transducers (up to 70 MHz for
rodent imaging). The associated enhanced signal processing at
rapid frame rates (132 frames/second), with superior resolution1,
enables quality ultrasound imaging in small animals (Deshpande
et al., 2010; Stuart et al., 2011). The specific probe used in this
study, the 21 MHz MS250 probe, has a resolution of 75 µM
axial by 165 µm lateral2. Importantly, rapid real-time imaging
allows longitudinal measurements of the structure and function
of small structures without significant impact on the animal or its
physiology.
While the current literature highlights many uses of high-
frequency ultrasound in rodent cardiovascular models (Coatney,
2001; Slama et al., 2003; Chen et al., 2012), imaging of the
abdominal veins has not been widely described in animal
research. While many rat splanchnic veins can be readily
visualized using ultrasound (Knipp et al., 2003), there is no
report of a technique that observes several major splanchnic
vessels (both veins and arteries) at once with repeated measures
of the same location along a specific splanchnic vessel. The
ability to re-locate and measure a precise section along a
vessel is critical to allow the continuous evaluation of diameter
changes of that vessel during pharmacological interventions, or
in chronic pathological states. We have therefore developed a
technique for serial ultrasound imaging and measurement of
1http://www.visualsonics.com/products/vevo-2100
2www.visualsonics.com/customer/docs/product_info_vevo2100/Vevo_2100-Trans
ducers_v2.8.pdf
the splanchnic vessel diameters in the anesthetized rat with
the goal of providing a reproducible, longitudinal, and non-
invasive index of the capacitance function of these vessels.
Validation of this technique included determining if imaging
could reliably detect acute changes (seconds to minutes) in
splanchnic vein diameters caused by venoactive drugs. Another
focus was testing whether imaging could detect stable changes
in the diameter of splanchnic veins in chronic conditions such
as hypertension. Finally, this work was essential in developing
a tool that would allow interrogation of the role of the venous
circulation in drug-induced blood pressure changes. Specifically,
our laboratories are dedicated to understanding how serotonin
(5-HT, 5-hydroxytryptamine) lowers blood pressure chronically
(Diaz et al., 2008). In vitro work on isolated splanchnic veins
strongly supports the ability of 5-HT to cause direct venodilation
but not arterial dilation (Watts et al., 2015). As such, a validated
mechanism by which to investigate in vivo venous diameter
would allow us to connect in vitro and in vivo studies, a powerful
approach when investigating cause and effect. This work suggests
the feasibility of using serial ultrasound imaging to investigate
venous function in rodents.
MATERIALS AND METHODS
Animals
MSU Institutional Animal Care and Use Committee approved
all protocols used in this study. Male Sprague–Dawley rats at 6-
weeks of age (300–350 g; Charles River Laboratories,) were used
in all experiments. Rats were housed in a temperature–controlled
room (22◦C) with 12-h light/dark cycles and given standard chow
and distilled water ad libitum.
Ultrasound Imaging
All animals were anesthetized using isoflurane (1.5–2.5% in
oxygen, titrated to maintain stable heart rate (HR), respiration
rate, and body temperature). The upper abdomen was shaved and
depilatory cream (NairTM) applied below the xiphoid process.
Animals were positioned supine on a heated platform [Vevo 2100
Imaging Station (integrated rail system); Visualsonics, Toronto,
Canada], as shown in Figure 1A. Coupling gel was applied to
all four paws and the paws were taped to conductive pads on
the platform to allow continuous collection of HR, respiratory
rate, body temperature, and electrocardiograms (ECGs) during
ultrasound image collection. Body temperature was monitored
continuously, via a rectal probe, and maintained at 37◦C
throughout the experiment using the heated table and when
necessary, a supplemental heat lamp. Warmed ultrasound gel was
applied to the abdominal skin, just below the xiphoid process to
couple the transducer (21 MHz probe; Visualsonics MS250) for
imaging. The transducer head was locked in the adjustable arm
of the Vevo mechanical rail-system to allow accurate hands-free
transducer positioning during image collection. The height of the
transducer was set to apply minimal pressure to the abdomen
while still allowing adequate views of the abdominal vessels of
interest. Once the transducer was positioned, the x–y knobs of the
platform were used to move the transducer small increments in
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FIGURE 1 | (A) A mechanical rail was used to hold a 21 MHz linear probe perpendicular to the abdomen while collecting transverse images. Body temperature was
maintained at 37◦C. All measurements were made using images collected during expiration and during cardiac systole. (B) Transverse transducer placement (dotted
line) and corresponding images obtained (Images I, II, and III). The transducer placement to obtain the superior mesenteric vein (SMV)/ SpV view is ∼2 mm caudal to
the placement used to obtain the portal vein (PV) view. (C) A longitudinal image of the PV within a naïve rat shows the variability of the diameter of this vessel along
its length even when controlled for respiration and cardiac cycle.
the cranial and caudal directions to display the major abdominal
vessels significant to this study: abdominal aorta (AA), IVC, and
portal vein (PV) in the same view. Transverse B-mode images
were collected at 25 frames per second in two locations, as seen
in Figure 1B. In Image I, we focused on a transverse view at the
level of the PV exiting the liver, which provides simultaneous
cross-sectional images of the AA, IVC, and PV; these structures
are labeled as such. Image II displays the splenic vein (SpV),
the established landmark for locating the noted veins. Finally,
image III provides a transverse view ∼2 mm caudal to Image I,
at a level just below the branching of the SpV (shown in image
II), and shows the structures of the superior mesenteric vein
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(SMV), SpV, and IVC. Figure 1C shows a longitudinal image
of the PV (as it exits the liver) during systole and expiration.
All ultrasound images were saved as cine loops for subsequent
measurement and analyses of vessel diameters. This technique
was used to collect baseline and post dose images during drug
interventions. Ultrasound recordings from individual rats during
chronic studies were collected at the same time each day and
feeding schedule remained consistent throughout the studies.
We assumed venous pressure remained stable during each of
these interventions and cardiac function did not change, except
in DOCA animals. The AA was used as a control abdominal
blood vessel for which minimal dynamic changes in measureable
diameter were expected.
Ultrasound Image Analysis
All vessel diameter measurements were made by the same
ultrasonographer with considerable experience in the use of the
Vevo Imaging system. Cine loops of the images were viewed on
a desktop station using Vevo LAB 1.7.1 software (Visualsonic,
Toronto, Canada). All vessel diameters were measured using
image frames from periods of cardiac systole and during
expiration. Both vertical and horizontal diameters (vessel height
and vessel width) of vessel cross-sections were measured and then
averaged to obtain final values from each time point.
Time Course Studies
We performed two time course studies: (1) images were collected
for three animals every 5 min over the course of 45 min (acute);
(2) images were collected for five animals every 2 weeks over the
course of 8 weeks (chronic).
Blood Pressure Monitoring
Rats used in the sodium nitroprusside (SNP) and sarafotoxin
experiments were anesthetized with isoflurane (2% in oxygen)
and a femoral arterial catheter was implanted for blood pressure
monitoring. The catheter was placed through a 1–1.5 cm incision
in the left inguinal area into the left femoral artery immediately
prior to ultrasound imaging. The tip of the catheter was advanced
to the AA and the catheter was attached to a transducer connected
to a data acquisition system (Powerlab, ADinstruments) to
record mean arterial pressure (MAP) and HR during imaging.
Rats remained anesthetized throughout catheter placement and
subsequent imaging.
Vasodilation Study- Sodium
Nitroprusside (SNP)
After 3 min of baseline recordings of abdominal vessel images and
blood pressure, each animal received a 2 mg/kg bolus (0.3 mL, tail
vein) of SNP (5054, Sigma Chemical CO., St Louis, MO, USA).
Ultrasound images were collected every minute over 30 min with
30 min being the time at which MAP returned to near baseline
values. Data were collected at 5 min post-bolus, the point at which
the MAP had reach nadir while vessel diameters initial achieved
near maximum dilation during the 30 min of the experiment.
These maximum changes were reported graphically. MAP was
measured continuously via a femoral arterial catheter connected
to data acquisition software on an ADInstruments Powerlab
(Chart 7.0, Colorado Springs, CO, USA). The SpV was not used
as an endpoint in this particular study, but solely as a landmark.
Seven animals were used in this study.
Vasoconstriction Study- Sarafotoxin
(S6c)
After 3 min of baseline recordings of abdominal vessel images and
blood pressure, each animal received a 5 ng/kg bolus (0.3 mL, tail
vein) of S6c (88-9-35, American Peptide, Sunnyvale, CA, USA).
Ultrasound images were collected every minute over 15 min
at which time all imaged vessels and MAP had returned back
to baseline values. Data was graphed at 5 min’ post-bolus, the
point of maximum vessel diameter change. MAP was measured
continuously via a femoral arterial catheter connected to data
acquisition software on an ADInstruments Powerlab (Chart 7.0,
Colorado Springs, CO, USA). The SpV was not used as an
endpoint in this particular study, but solely as a landmark. Five
animals were used in this study.
Deoxycorticosterone Acetate-Salt Study
(DOCA-Salt)
All rats used during the DOCA-salt study underwent a left
uninephrectomy. A DOCA pellet was implanted subcutaneously
in half of the rats to deliver the drug at a dose of 200 mg/kg.
The other rats underwent a SHAM pellet surgery (SHAM group).
All rats were switched from distilled drinking water, to water
containing 1% NaCl plus 0.2% KCl for 4 weeks. All rats were
imaged at baseline (prior to any intervention), and again 4 weeks
after surgery/pellet implantation. Systolic arterial pressure was
measured 4 weeks after surgery in conscious rats via the tail cuff
method (Malkoff, 2005; Kent Scientific Corp, CODA 6); this was
the only time blood pressure was measured. There were four
animals in each group: DOCA-salt and SHAM.
Data Analysis
Values were either expressed as mean ± SEM of the number of
animals in the experiment, or a percent change from baseline.
The baseline was determined by 3 min of image collection,
prior to injection or during the 1st day of imaging prior to
treatment. Statistical analyses were performed using paired two-
tailed t-tests when comparing vessel images to baseline values.
A repeated measures ANOVA were performed when comparing
vessel diameter values at different time points in timed studies.
(GraphPad Prism 6). In all cases, a p-value of <0.05 was
considered significant.
RESULTS
Ultrasound Transducer Placement
The splanchnic vein diameters varied considerably along the
length of those vessels within the same rat as shown in Figure 1C
and it was therefore imperative that a landmark be identified to
allow repeated placement of the transducer at the exact location
along a particular vein. Preliminary work suggested the SpV
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could be used as a landmark to locate and differentiate the PV
and the SMV as shown in Figure 1B, image II. Because it was
important to visualize the branching of the SpV off the parent
vessels and to include multiple vessels of interest within the same
view, a transverse positioning of the ultrasound transducer as
seen in Figure 1A was determined to provide the optimal views
for measurements of the PV, SMV, SpV, IVC, and AA diameters.
In addition, the use of high-frequency ultrasound allowed the
collection of images throughout the cardiac and respiratory cycles
despite the rapid heart and respiratory rates of rats. Data could be
generated from vessels during systole and exhalation specifically.
Acute Time Course Study
Vessel diameters measured every 5 min in anesthetized rats
were unchanged with no statistical difference from baseline
diameters through at least 45 min as seen in Figure 2. The
diameters remained within 0.75 ± 0.15% (PV), 0.2 ± 0.09%
(SMV), 0.5 ± 0.12% (IVC), and 0.38 ± 0.06% (AA) of baseline
measurement for each noted vessel. The SpV was not imaged in
this particular study.
Acute Pharmacologic Intervention
Studies
The venodilator SNP and the venoconstrictor S6c were used
in separate experiments to investigate the ability of our
imaging method to detect acute drug-induced changes in venous
diameter. A single iv bolus of SNP at 2 mg/kg caused significant
peak increases in PV, SMV, SpV, and IVC diameters by 5 min post
drug administration as seen in Figures 3A,B; (PV: 34.70 ± 2.2%,
SMV: 28 ± 4.1%, SpV: 39.3 ± 4.7%, and IVC: 6.6 ± 4.8%
change from baseline). Actual diameters of vessels at baseline are
reported in the foundation of each bar. In contrast, there was
little change in the diameter of the AA to SNP despite MAP
being significantly reduced by 29 ± 4 mmHg. In separate rats,
a single 5 ng/kg iv bolus of S6c caused a peak decrease in the
diameters of the SMV (11.9 ± 2.0%), PV (20.5 ± 1.6%), and
SpV (13.5 ± 2%) 5 min after injection, while MAP increased
6 ± 2 mmHg as shown in Figures 4A,B. The percent change
FIGURE 2 | Under isoflurane anesthesia, animals were imaged every
5 min over 45 min to determine the stability and consistency of each
vessel diameter. Points on the graph represent vessel diameters
(means ± SEM of three animals).
from baseline in vein diameter for both PV and SMV in the
presence of S6c were statistically significant (p-value of <0.05)
with SMV (p-value 0.067) and MAP (p-value 0.105) close to
significance. The SMV image was not included in Figure 4B
since SMV did not show a statistical significance in the presence
of sarafotoxin. There was little change in the diameters of the
IVC or AA. Baseline diameters are reported in the foundation of
each bar.
In addition, the arterial catheter which was placed in the
femoral artery to measure MAP, during each acute pharmacologic
intervention study, had no significant affect on the diameter of
the PV, SMV, or AA when compared to similar imaged vessels
without an arterial catheter (data not shown). There was a modest
reduction in the IVC diameter of animals with (3.13± 0.11 mm)
and without an arterial catheter (3.34 ± 0.05 mm; p < 0.05).
These differences could possibly be attributed to the larger
variability in the diameter size of the IVC, or be a response
to occlusion of the femoral artery during catheter insertion. It
is important to note, measurements were always compared to
baseline, as our focus was on change from baseline rather than
actual diameter changes.
Chronic Time Course Study
In a longitudinal imaging study, we evaluated the stability of
the splanchnic veins and AA diameters measurements within
an animal when acquired every 2 weeks, over 8 weeks. Vascular
diameters measured using our imaging technique were extremely
stable over 8 weeks, showing the average of the percent changes
from baseline at 8 weeks to be within 2.0 ± 0.5% (PV),
0.95 ± 0.2% (SMV), 11.7 ± 8% (IVC), and 0.9 ± 0.6% (AA), as
shown in Figure 5A. The SpV was not imaged in this particular
study. There was no statistical difference between the time
points of the imaged vessels. These findings support the ability
to consistently relocate a specific cross-section of abdominal
vessel of interest over multiple imaging sessions spanning many
weeks within an individual animal. Interestingly, vessel diameters
remained stable despite a steady body weight gain (200 g) over the
course of the experiment (Figure 5B). All animals used in these
studies were mature rats (10–12 weeks of age at the start of each
experiment) with stable body lengths, however.
Deoxycorticosterone Acetate-Salt Study
(DOCA-Salt)
We applied our imaging method to an experimental model
of hypertension, DOCA-salt hypertension, in which we have
previously demonstrated abnormalities of venous capacitance
regulation (Fink et al., 2000). The current experiment involved
ultrasound imaging of splanchnic vessels at baseline and again
after 4-weeks of established DOCA-salt hypertension. While
vascular diameters were similar in the two groups of rats at
baseline prior to treatment (less than a 4% difference in any
vessel diameters between groups prior to treatment), we observed
an overall increase in the vessel diameters of DOCA-salt treated
animals compared with vehicle controls at 4 weeks of treatment
as quantified and imaged in Figures 6A,B. Diameters increased
significantly from baseline in the DOCA-salt treated group,
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FIGURE 3 | (A) Percent change from baseline (baseline measured 3 min prior to drug treatment) of vessel diameters and MAP at 5 min post SNP i.v bolus. Bars
represent means ± SEM of seven animals. Asterisks depicts statistically different from baseline, P < 0.05. (B) Images of PV, IVC, SMV, and AA at baseline and 5 min
post SNP. Baseline diameters of vessels are shown in the foundation of each bar.
32.3 ± 4.6% (PV), 30.8 ± 6.7% (SMV), 20.6 ± 6.4% (IVC),
44.3 ± 4% (SpV), but not in the AA 16.2 ± 6.9% of the DOCA-
salt treated group or vehicle group, 0.1 ± 0.4% (PV), 0.7 ± 2.1%
(SMV), −6.8 ± 4.7% (IVC), 0.7 ± 11.5% (SpV), and 0.9 ± 1.4%
(AA). Tail-cuff blood pressure was 67 ± 4 mmHg higher in
DOCA-salt versus SHAM rats.
DISCUSSION
The goal of the present study was to develop and validate a
non-invasive imaging method to make reliable and reproducible
serial measurements of splanchnic vein diameters in anesthetized
rats as an aid to understanding the role of vascular capacitance
in cardiovascular regulation. We investigated several different
vein segments (PV, SMV, IVC, and SpV) because multiple veins
contribute to splanchnic vascular capacitance function, and each
segment is unique in terms of structure and contractile regulation
(Schmitt et al., 2002). Our approach to this goal featured
the use of: high frequency ultrasound; an adjustable arm and
mechanical rail-system to allow for accurate, stable, hands-free
transducer positioning during image collection; identification
of reliable anatomical landmarks to facilitate reproducible
transducer location; and the measurement of vessels during
systole and expiration only (as cardiac and respiratory cycles
strongly influence the dimensions of the compliant abdominal
veins). The PV, SMV, and SpV all showed marked changes when
rats were infused with either S6c or SNP, while the IVC remained
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FIGURE 4 | (A) Graph represents the percent change from baseline (measured 3 min prior to drug treatment) of vessel diameters and MAP at 5 min post S6c i.v
bolus. Bars represent means ± SEM of five animals. Asterisks depicts statistically difference from baseline, P < 0.05. (B) Images of PV, IVC, and AA at baseline and
5 min post S6c. Baseline diameters of vessels are shown in the foundation of each bar.
relatively stable. This may occur because the effectors of S6c
and SNP are differently functional in these compared veins (e.g.,
is the amount of ETB receptors different, is the expression of
guanylate cyclase different, respectively?). Alternatively, diameter
changes to the PV, SMV, and SpV may lead to compensatory
changes in the IVC that mask effects that might be seen in an
isolated IVC. The varying responses of specific vessels in vivo
highlight the importance of simultaneous and collective diameter
measurements.
Our initial study showed that use of this approach produced
quite stable measurement of vessel diameters over 45 min in
anesthetized, temperature-controlled rats. The stability of the
vessel diameters over this time period, in the absence of any
intervention, allowed us to conduct subsequent experiments to
examine the acute effects of venoactive drugs on splanchnic
vessel diameters. Administration of the venodilator SNP and
the venoconstrictor S6c resulted in anticipated increases and
decreases in splanchnic venous diameters, respectively. These two
compounds were chosen because of their relative venoselectivity.
This difference in reactivity highlights one of the many
differences between veins and arteries, including veins possessing
lower smooth muscle content and exposure to lower levels of
cyclic strain (Sung et al., 2007). In isolated rat veins and arteries,
S6c causes a venoconstriction but not an arterial constriction
(Tykocki et al., 2009). This was the best tool we had available
that would permit relatively selective venoconstriction and, used
with SNP as a recognized vasodilator, demonstrates that we could
observe and quantify both venous constriction and dilation.
It is important to note that we did not measure pressure
within the abdominal veins during image acquisition; therefore
firm conclusions cannot be drawn about whether the observed
diameter changes were primarily passive or active in nature.
However, in a previous study (Schwarzacher et al., 1992) in
rabbits that reported changes in the diameter of the abdominal
vena cava in response to venoactive drugs, only very small
alterations in venous pressure were observed. Thus the diameter
changes we observed were likely due to active alterations in
venous smooth muscle tone.
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FIGURE 5 | (A) Vessel diameters imaged every 2 weeks through 8 weeks
(means ± SEM of five animals). (B) Body weight changes of the same animals
over the 8-week time course. Bars represent means ± SEM of five animals.
In order to validate this imaging technique for use in
more chronic longitudinal studies, in a further experiment
we investigated the stability of the splanchnic vein and AA
diameters within an animal when acquired every 2 weeks
over an 8 weeks period. The key to this approach was the
ability to accurately relocate a specific cross-section of the
splanchnic vessel of interest. The consistency of vessel diameter
measurements observed in this chronic time course study
indicates that these vessels can serve as their own control in
experiments examining the potential impact of interventions on
long-term changes in vascular diameter. Therefore, we applied
our imaging technique to study splanchnic venous diameters
in an experimental model of chronic hypertension, i.e., DOCA-
salt hypertension. The results showed a significantly increased
diameter of all the splanchnic veins in DOCA-salt rats, whereas
no increases were observed in SHAM rats. We have previously
reported increased venoconstriction in conscious DOCA-salt
rats (Fink et al., 2000) so anticipated that we would observe
reduced splanchnic venous diameters in these animals. However,
venomotor tone in splanchnic veins is primarily controlled
by sympathetic activity, and isoflurane anesthesia is known to
dramatically reduce sympathetic activity (Bencze et al., 2013).
So the increases in venous diameters we observed in DOCA-salt
rats under anesthesia are likely due to passive effects (unopposed
FIGURE 6 | (A) Percent change from baseline (baseline measured prior to
DOCA-salt treatment) of vessel diameters compared to 4-weeks post
DOCA-salt treatment. Bars represent means ± SEM of four animals per
treatment group. Asterisks depict statistically difference from baseline,
P < 0.05. (B) Images of PV, IVC, and AA at baseline and 4-weeks post
DOCA-salt treatment.
by sympathetic venoconstriction) of the volume expansion and
cardiac hypertrophy that occur in chronic DOCA-salt rats
(Kobrin et al., 1990; Titze et al., 2006). This experiment highlights
the complexities of evaluating moment-to-moment regulation
of venous diameter; and indicates the desirability of using
multiple, and minimally invasive, approaches to that evaluation.
Nevertheless, the results support the ability of our vein imaging
technique to detect chronic, physiologically significant changes
in venous diameter in intact (albeit anesthetized) rats.
There are some additional limitations to the current study that
deserve mention. First, we only studied a relatively small number
of male Sprague–Dawley rats between 6 and 20 weeks of age.
Venous diameters measured by ultrasound vary by age and sex
in humans (Kutty et al., 2014; Gui et al., 2015) and are likely
to do so in rats as well. Likewise, it is quite possible that the
approach described here may need to be modified if applied to
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other strains of rats, to female rats, or to sexually immature or
old rats. Second, although we found that weight gain of ∼200 g
(∼80% increase) did not significantly affect the diameters of any
abdominal vein, studies in humans suggests that venous diameter
correlates modestly with body surface area and height (Gui et al.,
2015). Third, all animals were imaged only in one spatial plane,
i.e., supine. It is possible that altering the posture of the rat
would result in different findings for splanchnic vein diameters.
Four, since each vessel of interest courses a distinct 3-dimensional
plane, it is acknowledged that the combined image may not
represent exact perpendicular views of all three vessels at the
same time. However, obtaining a single images depicting all three
vessels makes possible the evaluation of simultaneous changes
to these various vessel sizes that is not possible with constant
repositioning of the transducer over each separate vessel. This
includes the important ability of being able to directly compare
and contrast arterial vs. venous responses. Finally, a relevant
consideration for any measurement technique is the time and
effort required to master it (Bowra et al., 2015) but since all
values here were obtained by a single highly experienced rodent
ultrasonographer, we cannot comment on how long it would
take for a novice to achieve the kind of stable, reproducible
measurements we report.
CONCLUSION
Although, ultrasound imaging the abdominal vessels, particularly
the PV and IVC, is not novel in experimental research or
clinical settings, investigation of diameter change in multiple
splanchnic vessels is novel as they relate to venous capacitance.
There is no current publication that measures vein diameters
in the splanchnic vasculature, a highly capacitive and compliant
region important in blood pressure regulation. We anticipate
that this technique will be useful in a number of different ways.
The goal of the present study was to lay the foundation for
repeatable measures, and illustration of changes in one model
in which alterations in venous function have been suggested
(e.g., the DOCA-salt model). Once we, and hopefully others,
accept this type of approach than we can begin to interrogate
disease models that would benefit from investigate of the venous
circulation. These include other models of experimental and
genetic hypertension, hyperlipidemia, obesity and heart failure.
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